A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer
Conditions
- Extensive-stage Small-cell Lung Cancer
Interventions
- DRUG: BL-B01D1
- DRUG: PD-1 monoclonal antibody
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Collaborators